IGF2BP3 and colonic neoplasm: IGF2BP3 expression is elevated in colon cancers and was shown to be associated with increased tumor angiogenesis, growth, and poor prognosis (Lochhead et al. 2012; Shantha Kumara et al. 2015; Xu et al. 2019; Yang et al. 2020).